Karyopharm Therapeutics Inc. - COM (KPTI)

Historical Portfolio Holders from Q1 2014 to Q1 2024

All holders as of March 31, 2024
Q1 2024
Type / Class
Equity / COM
Shares, excl. options Q1 2024
72.5 M
Holdings value Q1 2024
$109 M
Value change Q1 2024
+$4.74 M
Grand Portfolio weight change Q1 2024
+0%
Number of holders
105
Number of buys Q1 2024
52
Number of sells Q1 2024
-49
Average buys Q1 2024 %
+0%
Average sells Q1 2024 %
0%
CUSIP
48576U106
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q1 72.5 M $109 M +$4.74 M $1.51 105
2023 Q4 70.7 M $61.2 M -$4.33 M $0.87 115
2023 Q3 74.1 M $99.3 M -$10.7 M $1.34 112
2023 Q2 80 M $143 M -$18.6 M $1.79 131
2023 Q1 87.2 M $339 M -$32.8 M $3.89 125
2022 Q4 98 M $333 M +$100 M $3.40 148
2022 Q3 64.2 M $351 M -$1.86 M $5.46 134
2022 Q2 66.4 M $299 M -$6.98 M $4.51 139
2022 Q1 58.9 M $432 M +$112 M $7.37 128
2021 Q4 44.1 M $283 M +$1.31 M $6.43 134
2021 Q3 55 M $321 M -$27 M $5.82 128
2021 Q2 58.6 M $604 M -$13.8 M $10.32 148
2021 Q1 59 M $621 M -$47.5 M $10.52 161
2020 Q4 62.5 M $967 M -$61.5 M $15.48 157
2020 Q3 64.3 M $939 M -$114 M $14.60 146
2020 Q2 69.7 M $1.32 B +$56.6 M $18.94 148
2020 Q1 67 M $1.29 B +$217 M $19.21 134
2019 Q4 58.9 M $1.13 B -$54.7 M $19.17 147
2019 Q3 58.5 M $563 M +$83.6 M $9.62 105
2019 Q2 51.1 M $306 M +$9.7 M $5.99 100
2019 Q1 51.1 M $298 M +$12.3 M $5.84 102
2018 Q4 49.1 M $460 M +$67.9 M $9.37 113
2018 Q3 43.3 M $737 M -$819 K $17.03 117
2018 Q2 43.3 M $735 M +$217 M $16.99 107
2018 Q1 30.9 M $415 M +$169 K $13.42 89
2017 Q4 30.8 M $296 M +$20.1 M $9.60 86
2017 Q3 28.7 M $316 M +$10.7 M $10.98 74
2017 Q2 27.6 M $250 M +$6.05 M $9.05 68
2017 Q1 26.8 M $345 M +$45.3 M $12.84 78
2016 Q4 25.5 M $239 M +$21.2 M $9.40 84
2016 Q3 23.1 M $224 M +$31.5 M $9.73 74
2016 Q2 20 M $134 M -$8.39 M $6.71 72
2016 Q1 21.2 M $189 M -$5.33 M $8.92 74
2015 Q4 21.2 M $281 M -$26.1 M $13.25 84
2015 Q3 23.5 M $248 M -$7.32 M $10.53 88
2015 Q2 22.1 M $602 M +$39.3 M $27.21 85
2015 Q1 20.8 M $636 M +$53.6 M $30.61 84
2014 Q4 18.5 M $691 M +$48.1 M $37.43 79
2014 Q3 16.7 M $583 M +$52.3 M $34.94 69
2014 Q2 15.1 M $703 M +$235 M $46.55 76
2014 Q1 10.1 M $311 M +$33.6 M $30.89 58